External control cohorts for the single-arm LIBRETTO-001 trial of selpercatinib in RET+ non-small-cell lung cancer

BACKGROUND: Data for selpercatinib [a selective REarranged during Transfection (RET) inhibitor] from a single-arm trial (LIBRETTO-001, NCT03157128) in RET-fusion-positive advanced/metastatic non-small-cell lung cancer (NSCLC) were used in combination with external data sources to estimate comparativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolfo, C., Hess, L.M., Jen, M.-H., Peterson, P., Li, X., Liu, H., Lai, Y., Sugihara, T., Kiiskinen, U., Vickers, A., Summers, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434413/
https://www.ncbi.nlm.nih.gov/pubmed/35930972
http://dx.doi.org/10.1016/j.esmoop.2022.100551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434413/
https://www.ncbi.nlm.nih.gov/pubmed/35930972
http://dx.doi.org/10.1016/j.esmoop.2022.100551

Ejemplares similares